Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Indian Journal of Forensic Medicine & Toxicology
Mazin Maky Thamer1 , Chee Fah Wong2 , Zafir Hassan Ghali3
Unknown Affiliation
Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Estimation of Interleukin-4 (IL-4) and Interleukin-6 (IL-6) Levels in Sera From Patients with Type 2 Diabetes Mellitus Mazin Maky Thamer1 , Chee Fah Wong2 , Zafir Hassan Ghali3
Indian Journal of Forensic Medicine & Toxicology Vol. 15 No. 1 (2021): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v15i1.13660

Abstract

Type-2 diabetes mellitus is the most common chronic metabolic disorder characterized by elevation ofblood glucose concentration (hyperglycemia) due to defect in carbohydrate, lipid and protein metabolism.Cytokines have an important role in impairing insulin signaling and selective destruction of insulin-producingbeta cells. Thus, the second type of diabetes can be characterized as an immune-mediated disease. This studyaimed to evaluate the serum levels of Interleukin-4 (IL-4) and Interleukin-6 (IL-6) of patients with type 2diabetes mellitus among cases from Wasit province-Iraq. A total of 90 randomly selected subjects fromWasit province – Iraq: (60) patients with T2DM, and (30) apparently healthy subjects with normal fastingblood sugar as a control group. Enzyme-linked immunosorbent assay (ELISA) was used to measure thelevels of interleukin-4 IL-4 and interleukin -6 in sera from patients with type-2 diabetes mellitus. The resultsof this study showed that IL-4 concentrations had a non-significant difference when compared patients withtype-2 diabetes mellitus with the control group (154 ± 7.00 versus (vs) 151.49 ± 21, P-value (P) = > 0.05).While patients with T2DM revealed elevated serum levels of IL-6 compared to control group (B 637.1 ±355.9 versus 266.3 ± 128.8, P = < 0.001).
Co-Authors